Adductor Canal Block With Posterior Capsular Injection for Total Knee Replacement

NCT01805661 | Completed

• 1 other identifier: 12-10-002
• Study Type: interventional
• Target: 56
• Locations: 1 country
• Sites: 1

Brief Summary

To compare early ambulation and ability to participate in rehabilitation in patients undergoing total knee replacement using two different nerve block techniques for pain control. The 2 methods are 1) Adductor canal block with posterior capsular injection 2) femoral nerve block with tibial nerve block

Conditions

Pain; Osteoarthritis

Keywords

early ambulation; knee arthroplasty

Outcome Measures

Primary Outcomes (1)

• Ability to ambulate post operatively.

  Ability to ambulate and perform tasks of the rehabilitation program and reach rehabilitation milestones after total knee arthroplasty.

  Up to 3 days (72 hours) post surgery.

Secondary Outcomes (2)

• Pain scores at rest and with knee flexion.

  Up to 3 days ( 72 hours) after surgery

• Pain Medication Consumption

  Up to 3 days (72 hours) post surgery

Study Arms (2)

Femoral With Tibial Nerve Block

ACTIVE COMPARATOR

Continuous femoral nerve block with catheter and selective tibial nerve block in the popliteal fossa

Procedure: Femoral with Tibial Nerve Block

Canal Block and Capsular Injection

EXPERIMENTAL

Adductor canal block with a continuous catheter and ultrasound guided posterior capsular injection with local anesthetic solution.

Procedure: Canal Block and Capsular Injection

Interventions

Canal Block and Capsular Injection PROCEDURE

Continuous Adductor canal block with 15-30ml of ropivacaine 0.1% with epinephrine 1:400,000 followed by an infusion of ropivacaine 0.1% at 6 ml per hour for 2 days post operatively. This is combined with ultrasound guided posterior capsular knee injection with 30 ml ropivacaine 0.1% with epinephrine 1:400,000.

Canal Block and Capsular Injection

Femoral with Tibial Nerve Block PROCEDURE

Continuous femoral nerve block with 15 ml of ropivacaine 0.1% followed by an infusion of ropivacaine 0.1% at 6 ml per hour for 2 days after surgery combined with tibial nerve block in the popliteal fossa with ropivacaine 0.1% up to 15 ml.

Femoral With Tibial Nerve Block

Eligibility Criteria

• Age: 18 Years - 80 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Patients having primary, unilateral total knee arthroplasty
• ages 18 - 80

You may not qualify if:

• history of neurological disease
• neuropathy
• diabetes
• major systemic illness
• pregnancy
• chronic narcotic use
• allergy to local anesthetic solution or NSAIDS
• inability to give consent or cooperate with the study protocol
• BMI\> 40

Sponsors & Collaborators

• Trinity Health Of New England: lead

Study Sites (1)

Saint Francis Hospital and Medical Center

Hartford, Connecticut, 06105, United States

Location

MeSH Terms

Conditions

Pain; Osteoarthritis

Condition Hierarchy (Ancestors)

Neurologic Manifestations; Signs and Symptoms; Pathological Conditions, Signs and Symptoms; Arthritis; Joint Diseases; Musculoskeletal Diseases; Rheumatic Diseases

Study Officials

• Sanjay Sinha, M.D.

  Saint Francis Hospital and Medical Center

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: SINGLE
• Who Masked: CARE PROVIDER
• Purpose: TREATMENT
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: March 4, 2013
• First Posted: March 6, 2013
• Study Start: March 1, 2013
• Primary Completion: December 1, 2013
• Study Completion: December 1, 2013
• Last Updated: March 17, 2015

Record last verified: 2015-01

Locations

US (1)